The development of drugs modulating GLUT2 to treat diabetes has not been practical, owing to several reasons: First, because of the close structural and functional similarity between the GLUT family members (specifically, the class I GLUT transporters, including GLUT1, GLUT3, and GLUT4) [114,115]. The gene discussed is SLC2A4; the disease is diabetes mellitus.